Your browser doesn't support javascript.
loading
Pralsetinib treatment for multiple RET fusions in lung adenocarcinoma: a case report.
Cao, Xiangming; Liu, Xiongwei; Wang, Simin; Liu, Zhen; Ren, Xin; Sun, Debin; Deng, Lichun.
Afiliación
  • Cao X; Department of Oncology, The Affiliated Jiangyin Hospital of Southeast University Medical College, Wuxi, China.
  • Liu X; Department of Oncology, The Affiliated Jiangyin Hospital of Southeast University Medical College, Wuxi, China.
  • Wang S; Department of Oncology, The Affiliated Jiangyin Hospital of Southeast University Medical College, Wuxi, China.
  • Liu Z; Department of Oncology, The Affiliated Jiangyin Hospital of Southeast University Medical College, Wuxi, China.
  • Ren X; Department of Oncology, The Affiliated Jiangyin Hospital of Southeast University Medical College, Wuxi, China.
  • Sun D; Institute of Biomedical Research, Genecast Biotechnology Co., Ltd, Wuxi, China.
  • Deng L; Department of Oncology, The Affiliated Jiangyin Hospital of Southeast University Medical College, Wuxi, China.
J Int Med Res ; 50(6): 3000605221105368, 2022 Jun.
Article en En | MEDLINE | ID: mdl-35751411
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Adenocarcinoma / Carcinoma de Pulmón de Células no Pequeñas / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Límite: Humans / Male Idioma: En Revista: J Int Med Res Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Adenocarcinoma / Carcinoma de Pulmón de Células no Pequeñas / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Límite: Humans / Male Idioma: En Revista: J Int Med Res Año: 2022 Tipo del documento: Article País de afiliación: China